Sponsor Pipeline

STCube, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07306624 Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer Non Small Cell Lung Cancer Recruiting
Phase 1/2
NCT06873763 Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/… Metastatic Colorectal Cancer (CRC) Recruiting
Phase 1
NCT07656038 Nelmastobart in Combination With Tas-102 and Bevacizumab in Recurrent/Metastatic… Colonrectal Cancer (CRC) Not Yet Recruiting
Disease Areas
Colorectal Cancer (2) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1)
Get alerts when STCube, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free